Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
65
TRV Quote, Financials, Valuation and Earnings
Last price:
$260.62
Seasonality move
:
3.5%
Day range:
$260.44 - $266.09
52-week range:
$200.21 - $269.56
Dividend yield:
1.58%
P/E ratio:
12.35x
P/S ratio:
1.32x
P/B ratio:
2.16x
Volume:
1.8M
Avg. volume:
1.3M
1-year change:
20.01%
Market cap:
$60.1B
Revenue:
$46.4B
EPS (TTM):
$21.47
Analysts' Opinion
-
Consensus RatingThe Travelers Companies has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 12 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $269.15, The Travelers Companies has an estimated upside of 1.52% from its current price of $265.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $215.21 representing 100% downside risk from its current price of $265.13.
Fair Value
-
According to the consensus of 17 analysts, The Travelers Companies has 1.52% upside to fair value with a price target of $269.15 per share.
TRV vs. S&P 500
-
Over the past 5 trading days, The Travelers Companies has overperformed the S&P 500 by 1.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Travelers Companies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Travelers Companies has grown year-over-year revenues for 18 quarters straight. In the most recent quarter The Travelers Companies reported revenues of $12B.
Earnings Growth
-
The Travelers Companies has grown year-over-year earnings for 2 quarters straight. In the most recent quarter The Travelers Companies reported earnings per share of $8.96.
Enterprise value:
-21B
EV / Invested capital:
-0.58x
Price / LTM sales:
1.32x
EV / EBIT:
-3.19x
EV / Revenue:
-0.45x
PEG ratio (5yr expected):
0.18x
EV / Free cash flow:
-2.31x
Price / Operating cash flow:
6.75x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.84%
Net Income Margin (TTM):
10.77%
Return On Equity:
19.17%
Return On Invested Capital:
14.66%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $36.9B | $41.4B | $46.4B | $10.9B | $12B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $11.75 | $12.79 | $21.47 | $6.99 | $8.96 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $101.4B | $103.7B | $97B | $106.4B | $112.6B | |
| Total Assets | $116.8B | $120.5B | $115.7B | $126B | $133.2B | |
| Current Liabilities | $4.6B | $4.4B | $4.1B | $3.9B | $3.8B | |
| Total Liabilities | $87.6B | $91.6B | $94.2B | $101.1B | $105.3B | |
| Total Equity | $29.2B | $28.9B | $21.6B | $24.9B | $27.9B | |
| Total Debt | $6.6B | $7.3B | $7.3B | $8B | $8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.5B | $7.7B | $9.1B | $2.1B | $2.1B | |
| Cash From Investing | -$3.7B | -$6.8B | -$7.3B | -$1.8B | -$1.7B | |
| Cash From Financing | -$2.7B | -$1.1B | -$1.7B | -$273M | -$422M | |
| Free Cash Flow | $6.5B | $7.7B | $9.1B | $2.1B | $2.1B | |
TRV
Sector
Market Cap
$60.1B
$618.6M
Price % of 52-Week High
98.36%
85.59%
Dividend Yield
1.58%
2.01%
Shareholder Yield
3.77%
3.87%
1-Year Price Total Return
20.01%
9.44%
Beta (5-Year)
0.606
0.715
Dividend yield:
1.58%
Annualized payout:
$4.15
Payout ratio:
19.02%
Growth streak:
19 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$257.54
200-day SMA
Buy
Level
$234.50
Bollinger Bands (100)
Buy
Level
241 - 258.4
Chaikin Money Flow
Buy
Level
222.1M
20-day SMA
Buy
Level
$251.74
Relative Strength Index (RSI14)
Buy
Level
65.68
ADX Line
Buy
Level
20.26
Williams %R
Sell
Level
-5.2302
50-day SMA
Buy
Level
$246.31
MACD (12, 26)
Buy
Level
4.08
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
511.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3241)
Sell
CA Score
(Annual)
Level (-1.4568)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.1577)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance.
Stock Forecast FAQ
In the current month, TRV has received 4 Buy ratings 12 Hold ratings, and 1 Sell ratings. The TRV average analyst price target in the past 3 months is $269.15.
-
Where Will The Travelers Companies Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Travelers Companies share price will rise to $269.15 per share over the next 12 months.
-
What Do Analysts Say About The Travelers Companies?
Analysts are divided on their view about The Travelers Companies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Travelers Companies is a Sell and believe this share price will drop from its current level to $215.21.
-
What Is The Travelers Companies's Price Target?
The price target for The Travelers Companies over the next 1-year time period is forecast to be $269.15 according to 17 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 12 analysts rate the stock a Hold.
-
Is TRV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Travelers Companies is a Hold. 12 of 17 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TRV?
You can purchase shares of The Travelers Companies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Travelers Companies shares.
-
What Is The The Travelers Companies Share Price Today?
The Travelers Companies was last trading at $260.62 per share. This represents the most recent stock quote for The Travelers Companies. Yesterday, The Travelers Companies closed at $265.13 per share.
-
How To Buy The Travelers Companies Stock Online?
In order to purchase The Travelers Companies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
